MTS

Indication:

MTS is indicated for the prophylaxis and chronic treatment of asthma. It is also indicated for the relief of symptoms of seasonal and perennial allergic rhinitis.

Dosage & Administration:

MTS should be taken once daily. For asthma, the dose should be taken in the evening. For allergic rhinitis, the time of administration may be individualized to suit patients’ need. Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening.

Adults and adolescents 15 years of age and older with asthma or allergic rhinitis: 10 mg tablet once daily in the evening
Children 6 to 14 years of age with asthma or allergic rhinitis: 5 mg tablet once daily in the evening
Children 6 month to 5 years of age with asthma or allergic rhinitis: 4 mg tablet daily in the evening

Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis and in patients less than 12 months of age with asthma have not been established yet.

Preparation:

MTS 10 mg tablets: Each film-coated tablet contains montelukast sodium USP 10 mg.